Get your patient on Benzonatate - Benzonatate capsule (Benzonatate)

Medication interactionsSee all drug-to-drug interactions for this medication.
card icon

Benzonatate - Benzonatate capsule prescribing information

Indications & Usage

INDICATIONS AND USAGE

Benzonatate Capsule is indicated for the symptomatic relief of cough.

Dosage & Administration

DOSAGE AND ADMINISTRATION

Adults and Children over 10 years of age

Usual dose is one 100 mg or 200 mg capsule three times a day as needed for cough. If necessary to control cough, up to 600 mg daily in three divided doses may be given. Benzonatate Capsules should be swallowed whole. Benzonatate Capsules are not to be broken, chewed, dissolved, cut or crushed.

Contraindications

CONTRAINDICATIONS

Hypersensitivity to benzonatate or related compounds.

Adverse Reactions

ADVERSE REACTIONS

Potential Adverse Reactions to Benzonatate Capsules may include:

Hypersensitivity reactions including bronchospasm, laryngospasm,cardiovascular collapse possibly related to local anesthesia from chewing or sucking the capsule.

CNS: sedation; headache; dizziness; mental confusion; visual hallucinations.

GI: constipation; nausea; GI upset.

Dermatologic: pruritus; skin eruptions.

Other: nasal congestion; sensation of burning in the eyes; vague "chilly" sensation; numbness of the chest; hypersensitivity.

Deliberate or accidental overdose has resulted in death, particularly in children.

Description

DESCRIPTION

Benzonatate, a non-narcotic oral antitussive agent, is 2, 5, 8, 11, 14, 17, 20, 23, 26-nonaoxaoctacosan-28-yl p-(butylamino) benzoate; with a molecular weight of 603.7.

Referenced Image

Each Benzonatate Capsules USP contains: Benzonatate, USP 100 mg or 200 mg

Benzonatate Capsules USP also contain: D&C Yellow 10, gelatin, glycerin, methylparaben, propylparaben, shellac and titanium dioxide.

Pharmacology

CLINICAL PHARMACOLOGY

Benzonatate Capsule acts peripherally by anesthetizing the stretch receptors located in the respiratory passages, lungs, and pleura by dampening their activity and thereby reducing the cough reflex at its source. It begins to act within 15 to 20 minutes and its effect lasts for 3 to 8 hours. Benzonatate Capsule has no inhibitory effect on the respiratory center in recommended dosage.

How Supplied/Storage & Handling

HOW SUPPLIED

Benzonatate Capsules USP, 100 mg are available as yellow, oval soft gelatin capsules with'1'imprinted in white ink.

Bottles of 100
NDC 68094-798-50

Bottles of 500
NDC 68094-798-60

Benzonatate Capsules USP, 200 mg are available as yellow, oval soft gelatin capsules with'2'imprinted in white ink.

Bottles of 100
NDC 68094-901-50

Bottles of 500
NDC 68094-901-60

Store at 20° to 25°C (68° to 77°F) excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

PROTECT FROM LIGHT

Data SourceWe receive information directly from the FDA and PrescriberPoint is updated as frequently as changes are made available
Interactions Banner
Check medication interactionsReview interactions as part of your prescribing workflow

Benzonatate - Benzonatate capsule PubMed™ news

    Show the latest PubMed™ articles for Benzonatate - Benzonatate capsule